These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 2325588)
1. Caution required in developing HIV vaccine. Rabinoff M Med Hypotheses; 1990 Feb; 31(2):155-6. PubMed ID: 2325588 [No Abstract] [Full Text] [Related]
2. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope. Emini EA; Koff WC Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131 [No Abstract] [Full Text] [Related]
3. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor. Cohen J Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780 [No Abstract] [Full Text] [Related]
4. The future of research into rotavirus vaccine. Weijer C BMJ; 2000 Sep; 321(7260):525-6. PubMed ID: 10968800 [No Abstract] [Full Text] [Related]
5. [Promising experiments with DNA vaccine against HIV. A complete eradication of the virus is a formidable task]. Wahren B Lakartidningen; 1999 Feb; 96(7):722-5. PubMed ID: 10087774 [TBL] [Abstract][Full Text] [Related]
6. Statement on the hypothesis that an experimental polio vaccine was origin of HIV. World Health Organization Communications Office. World Health Organization Communications Office Trop Doct; 2001 Jul; 31(3):181. PubMed ID: 11444350 [No Abstract] [Full Text] [Related]
7. Is there a role for plant-made vaccines in the prevention of HIV/AIDS? Webster DE; Thomas MC; Pickering R; Whyte A; Dry IB; Gorry PR; Wesselingh SL Immunol Cell Biol; 2005 Jun; 83(3):239-47. PubMed ID: 15877601 [TBL] [Abstract][Full Text] [Related]
8. Update on HIV vaccines. Meldorf M; Corey L STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929 [TBL] [Abstract][Full Text] [Related]
9. [PolyEnv, a new strategy in the development of anti-HIV vaccines]. Molina CN Sidahora; 2001 Oct; ():7-11. PubMed ID: 11776248 [No Abstract] [Full Text] [Related]
10. Controversial HIV vaccine enters phase III trials amid skepticism. AIDS Alert; 1998 Dec; 13(12):133-4, 136. PubMed ID: 11366059 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 gp41: role in HIV entry and prevention. Chen YH; Xiao Y; Dierich MP Immunobiology; 2000 Jan; 201(3-4):308-16. PubMed ID: 10776787 [No Abstract] [Full Text] [Related]
12. Pediatric vaccine trials limited in U.S. AIDS Patient Care STDS; 1996 Apr; 10(2):134. PubMed ID: 11361698 [No Abstract] [Full Text] [Related]
13. Unwelcome guests with master keys: how HIV enters cells and how it can be stopped. Doms RW Top HIV Med; 2004; 12(4):100-3. PubMed ID: 15516706 [TBL] [Abstract][Full Text] [Related]
14. Adverse events after vaccination among HIV-positive persons, 1990-2016. Su JR; Ng C; Lewis PW; Cano MV PLoS One; 2018; 13(6):e0199229. PubMed ID: 29920551 [TBL] [Abstract][Full Text] [Related]